| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer
1 company
Nayak Sanjay is a Chief Strategy Officer at Ocular Therapeutix, Inc.. Recent SEC Form 4 filings include 0 buys and 8 sells.
Estimated insider holdings value: $3.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | OCUL Ocular Therapeutix, Inc. | Chief Strategy Officer | Sell | 1,759 | $8.28 | $14,564.52 | -0.5% | - | - | |
| Nov 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 1,878 | $12.04 | $22,611.12 | -0.7% | -30.4% | - | |
| Aug 25, 2025 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 1,885 | $12.04 | $22,695.40 | -0.7% | +1.9% | - | |
| May 23, 2025 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 1,862 | $7.17 | $13,350.54 | -0.7% | +66.2% | - | |
| Feb 24, 2025 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 1,895 | $6.84 | $12,961.80 | -0.7% | +3.3% | +33.3% | |
| Nov 25, 2024 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 1,814 | $9.00 | $16,326.00 | -1.0% | -26.1% | +33.4% | |
| Aug 23, 2024 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 1,832 | $9.02 | $16,524.64 | -1.0% | -6.5% | +35.0% | |
| May 23, 2024 | OCUL Ocular Therapeutix, Inc | Chief Strategy Officer | Sell | 2,274 | $5.84 | $13,280.16 | -1.3% | +59.1% | +25.9% |